조아제약
Financials
Valuation Metrics
조아제약's Market Cap is ₩168B. At end of 2025 it was ₩313B. Ranked #2374 of 2,421 in KR market (top 98%), #1599 of 1,640 on KOSDAQ (top 98%), #228 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 99%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 16.82B KRW | KR#2,374/2,421 Sec#228/231 |
| Revenue | 61.16B KRW | KR#1,691/2,421 Sec#112/231 |
| Net Income | -3.36B KRW | KR—/2,421 Sec—/231 |
| Total Assets | 73.57B KRW | KR#1,986/2,421 Sec#164/231 |
| Net Assets | 32.06B KRW | KR#2,154/2,421 Sec#192/231 |
| Employees | 279 | KR#846/2,421 Sec#72/231 |
| Value | ||
| P/B | 0.52x | KR#846/2,421 Sec#40/231 |
| P/S | 0.28x | KR#539/2,421 Sec#12/231 |
| FCF Yield | -31.41% | KR—/2,421 Sec—/231 |
| Profitability | ||
| ROE | -10.47% | KR#1,952/2,421 Sec#146/231 |
| ROA | -4.56% | KR#1,915/2,421 Sec#136/231 |
| Op. Margin | -6.76% | KR#1,916/2,421 Sec#128/231 |
| Revenue Growth | 1.50% | KR#1,424/2,421 Sec#140/231 |
| Financial Health | ||
| Debt Ratio | 129.48% | KR#1,788/2,421 Sec#199/231 |
| Total Debt | 24.54B KRW | KR#1,315/2,421 Sec#106/231 |
| FCF | -5.28B KRW | KR#1,509/2,421 Sec#119/231 |
| Cash | 2.37B KRW | KR#2,213/2,421 Sec#210/231 |
| Current Ratio | 1.10x | KR#1,602/2,421 Sec#161/231 |
| Performance | ||
| 1Y Return | -53.98% | KR#2,127/2,421 Sec#197/231 |
| 1M Return | -1.27% | KR#1,384/2,421 Sec#106/231 |
| From 52W High | -61.76% | KR#1,914/2,421 Sec#154/231 |
| 1Y MDD | -60.20% | KR#1,490/2,421 Sec#119/231 |
| Trading | ||
| Volume | 22,244 shares | KR#1,535/2,421 Sec#152/231 |
| Trading Value | 60.2M KRW | KR#1,774/2,421 Sec#180/231 |
| Foreign Own. | 0.00% | KR—/2,421 Sec—/231 |
| Per Share | ||
| EPS | -542 KRW | KR—/2,421 Sec—/231 |
| BPS | 5,175 KRW | KR#1,468/2,421 Sec#104/231 |
Company Info
Joa Pharmaceutical, established in 1996, was formed following the acquisition of Samgang Pharmaceutical Company in 1988. It operates the pharmacy franchise Medipharm as a subsidiary. The company produces and supplies over 200 pharmaceuticals and health foods, including Hepatos and Evathion, supported by over 100 Medical Representatives across 15 nationwide sales offices. Since beginning exports to Vietnam in 1995, Joa Pharmaceutical now exports over 150 product types to 23 countries, striving to become a global healthcare leader through innovative product development and brand competitiveness. Joa Pharmaceutical is headquartered in Yeongdeungpo-gu, Seoul Metropolitan City.